Variability in Antibiotic Use at Children's Hospitals
暂无分享,去创建一个
Jeffrey S Gerber | Susan E Coffin | Chris Feudtner | J. Gerber | S. Coffin | C. Feudtner | T. Zaoutis | M. Hall | Priya A Prasad | Theoklis E Zaoutis | Matt Hall | J. Newland | P. Prasad | C. Thurm | Jason G Newland | Cary Thurm
[1] J. Bartlett,et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] D. Pollock,et al. National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.
[3] Arjun Srinivasan,et al. Emergency department visits for antibiotic-associated adverse events. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Sharifzadeh,et al. Anti‐infectives‐induced adverse drug reactions in hospitalized patients , 2005, Pharmacoepidemiology and drug safety.
[5] L. Grohskopf,et al. Use of Antimicrobial Agents in United States Neonatal and Pediatric Intensive Care Patients , 2005, The Pediatric infectious disease journal.
[6] Alexander Kopp,et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. , 2006, The New England journal of medicine.
[7] F A Connell,et al. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. , 2000, Pediatrics.
[8] J. Bartlett. Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.
[9] Conan MacDougall,et al. Variability in Rates of Use of Antibacterials Among 130 US Hospitals and Risk-Adjustment Models for Interhospital Comparison , 2008, Infection Control & Hospital Epidemiology.
[10] J. Bartlett,et al. Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.
[11] J F Steiner,et al. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.
[12] R. Gaynes,et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] A. Pakyz,et al. Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers , 2009, Infection Control & Hospital Epidemiology.
[14] Ralph Gonzales,et al. Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.
[15] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[16] A. Pakyz,et al. Trends in antibacterial use in US academic health centers: 2002 to 2006. , 2008, Archives of internal medicine.
[17] L. Rice. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Carlos G. Grijalva,et al. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.
[19] R. Polk,et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] J. Shuster. Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care , 2011 .
[21] S. Cosgrove. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.
[23] J. Burke,et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Spencer E. Harpe,et al. Diversity of Antimicrobial Use and Resistance in 42 Hospitals in the United States , 2008, Pharmacotherapy.
[25] Forum on Emerging Infections. Antimicrobial Resistance: Issues and Options , 1998 .
[26] A. MacGowan,et al. Clinical implications of antimicrobial resistance for therapy. , 2008, The Journal of antimicrobial chemotherapy.
[27] P. Polgreen,et al. Antimicrobial Stewardship Programs in Pediatrics , 2009, Infection Control & Hospital Epidemiology.
[28] K. Kelleher,et al. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. , 2002, Archives of pediatrics & adolescent medicine.
[29] D. Gerding,et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.
[30] Joshua Borus,et al. Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.
[31] R. Platt,et al. Antimicrobial use in defined populations of infants and young children. , 2000, Archives of pediatrics & adolescent medicine.
[32] J. Hughes,et al. Trends in antimicrobial prescribing rates for children and adolescents. , 2002, JAMA.
[33] A. Ranaweera,et al. Antimicrobial resistance , 1999 .
[34] D. Paterson. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.